Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Goldman Sachs stock drops nearly 3% as Intel rout hits risk mood; GS investors eye Fed next week

Goldman Sachs stock drops nearly 3% as Intel rout hits risk mood; GS investors eye Fed next week

Goldman Sachs shares fell 2.9% to $927.27 Friday morning, dragging the Dow lower by about 204 points alongside American Express. The drop followed a wider market stumble after Intel’s weak outlook and tariff concerns. Goldman recently raised $2.8 billion for a new co-investment fund and hiked its 2026 gold price target to $5,400 an ounce. Investors await the Federal Reserve’s policy decision on January 28.
23 January 2026
··
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth shares rose 0.2% to $355.19 in late morning trading Friday after the company pledged to rebate ACA marketplace profits in 2026. The move follows a contentious Capitol Hill hearing on insurer competition and rising premiums. Investors await UnitedHealth’s January 27 earnings and 2026 outlook for signals on medical costs.
23 January 2026
··
Visa stock inches up as traders eye Jan. 29 earnings and UK fee-cap risk

Visa stock inches up as traders eye Jan. 29 earnings and UK fee-cap risk

Visa rose 0.1% to $326.63 in midday New York trading Friday, while Mastercard fell 1.3% and American Express dropped 2.3%. Investors are watching for Visa’s fiscal first-quarter results on Jan. 29. A UK court ruling has cleared the way for possible caps on cross-border card fees, but regulators have not set details or timing. Visa remains in a quiet period ahead of its earnings release.
23 January 2026
·
Rocket Lab stock rebounds as Neutron test rupture hangs over 2026 debut

Rocket Lab stock rebounds as Neutron test rupture hangs over 2026 debut

Rocket Lab shares rose 3.1% to $90.72 by late Friday morning after a Stage 1 tank rupture during Neutron rocket testing raised concerns about launch delays. The company is reviewing test data to assess impacts on its schedule, with an update expected during its February earnings call. Director Jon A. Olson sold 15,205 shares on Jan. 20, retaining 345,630. Rocket Lab completed its 80th Electron launch this week.
23 January 2026
····
Uber stock steadies as NYC tipping-law setback hits Uber Eats and robotaxi fears linger

Uber stock steadies as NYC tipping-law setback hits Uber Eats and robotaxi fears linger

Uber shares rose 0.2% to $82.75 after a U.S. judge rejected a bid to block New York City’s new delivery-app tipping rules. DoorDash gained 1%, while Lyft slipped 0.5%. Tesla’s robotaxi launch in Austin without safety monitors drew investor attention but left its stock little changed. New York’s state comptroller filed a shareholder proposal urging Uber to report on handling sexual harassment and assault claims.
23 January 2026
·····
Bank of America stock slips as credit-card rate-cap fight keeps BAC in focus

Bank of America stock slips as credit-card rate-cap fight keeps BAC in focus

Bank of America shares fell about 1.5% to $51.64 in late-morning New York trading as investors weighed a proposed 10% cap on credit card interest rates. The move follows reports the bank may launch new low-rate cards to comply with President Trump’s demands. Citigroup is considering a similar step. The Federal Reserve’s Jan. 27–28 meeting remains in focus for bank stocks.
23 January 2026
·
Eli Lilly stock slips as Novo’s Wegovy pill racks up 18,000+ scripts; earnings next

Eli Lilly stock slips as Novo’s Wegovy pill racks up 18,000+ scripts; earnings next

Eli Lilly shares fell 1.1% to $1,075.78 after Novo Nordisk’s new Wegovy pill logged over 18,000 U.S. prescriptions in its first full week. Investors are watching ahead of Lilly’s Feb. 4 earnings and an expected FDA decision on its own oral obesity drug by April. Several Lilly directors recently received stock units through a deferral plan.
23 January 2026
····
ServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earningsServiceNowServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earnings

ServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earningsServiceNowServiceNow stock jumps as Wall Street resets targets ahead of Jan. 28 earnings

ServiceNow shares rose 3.4% Friday to $132.88, rebounding after a six-day slump as investors await next week’s earnings. Cantor Fitzgerald and Jefferies cut price targets but kept positive ratings. The stock is down 16% in 2026, while the S&P 500 is up 1%. ServiceNow and OpenAI expanded their partnership to integrate new AI models into workflows.
23 January 2026
··
Coinbase stock slips as Grayscale’s new BNB ETF filing puts COIN back in the spotlight

Coinbase stock slips as Grayscale’s new BNB ETF filing puts COIN back in the spotlight

Coinbase shares fell 1.95% to $218.78 by midday Friday, despite bitcoin rising 0.7% to near $89,584. Grayscale’s SEC filing for a proposed BNB ETF named Coinbase as both prime broker and custodian. U.S. stocks slipped after Intel’s weak outlook, with traders watching for signals from next week’s Federal Reserve meeting. Crypto stocks were mixed, with Robinhood up 2.2% and Strategy Inc. gaining 1.4%.
23 January 2026
·····
Morgan Stanley stock price drops as bank shares slide; Fed decision next week looms

Morgan Stanley stock price drops as bank shares slide; Fed decision next week looms

Morgan Stanley shares fell 2.1% to $179.17 Friday as U.S. banks retreated on weaker market momentum ahead of next week’s Federal Reserve decision and a wave of corporate earnings. SpaceX IPO speculation increased after insider-sale filings and reports the company may tap Morgan Stanley for a lead role. Chief client officer Crawley Mandell sold 7,860 shares on Jan. 20, SEC filings show.
23 January 2026
··
Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson shares traded nearly flat at $218.59 by late Friday morning as Wall Street upgrades met renewed worries over federal talc lawsuits. A special master recommended allowing plaintiffs’ experts to testify that J&J talc products can cause ovarian cancer, affecting over 67,500 cases. The company reported Q4 sales up 9.1% to $24.6 billion and projected 2026 sales of up to $101 billion.
23 January 2026
··
Why Procter & Gamble stock is edging up today after earnings and new analyst upgrades

Why Procter & Gamble stock is edging up today after earnings and new analyst upgrades

Procter & Gamble shares rose 0.2% to $150.28 in late morning trading Friday after a 2.7% jump Thursday. Quarterly net sales missed estimates at $22.21 billion, with U.S. volumes down 1%, but adjusted earnings beat forecasts. JPMorgan and Wells Fargo raised price targets, citing focus on U.S. volumes and upcoming policy guidance. The company cut its fiscal 2026 diluted earnings growth forecast to 1%–6%.
23 January 2026
··
Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT

Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT

Walmart shares rose 0.3% to $118.20 Friday after Reuters reported the company will sell about 46 million PhonePe shares in the Indian payments unit’s IPO. The offering, expected to cut Walmart’s stake by roughly 12%, is entirely secondary, with proceeds going to selling shareholders. CEO transition is set for Feb. 1, and quarterly earnings are due Feb. 19.
23 January 2026
··
Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher Scientific shares fell 1.2% to $631.70 in late morning trading Friday, ending a two-day rally as investors awaited the company’s Jan. 29 earnings report. Peers Danaher and Agilent also declined. Traders are watching for management’s outlook on demand and margins. A recent minor debt security filing drew some attention but did not involve common stock.
23 January 2026
··
1 … 135 136 137 138 139 … 607

Stock Market Today

Ucore Rare Metals stock price jumps as ‘Project Vault’ keeps rare earths on traders’ screens

Ucore Rare Metals stock price jumps as ‘Project Vault’ keeps rare earths on traders’ screens

7 February 2026
Ucore Rare Metals shares jumped 14.7% to C$7.97 on Toronto’s TSX Venture Exchange Friday, rebounding after a steep drop as investors responded to U.S. critical-minerals policy moves. The U.S. Export-Import Bank described Project Vault as a $10 billion public-private stockpiling plan. Neodymium prices climbed 1.27% to 997,500 yuan a tonne on Feb. 6. Investors await details on Project Vault’s purchasing plans next week.
Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

7 February 2026
The Philadelphia Semiconductor Index jumped 5.7% to 8,048.6 on Friday, with Nvidia up 7.87% and AMD rising 8.28%. The surge followed new forecasts showing global chip sales could hit $1 trillion in 2026. Amazon expects a 50% increase in capital spending this year, fueling demand for chips. The Dow Jones crossed 50,000, helped by gains in chipmakers.
Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Go toTop